Φορτώνει......
Comparative assessment of platelet Gp(IIb/IIIa) receptor occupancy ratio with Eptifibatide/Tirofiban in patients presenting with ACS and undergoing PCI
BACKGROUND: The level of platelet inhibition by a Glycoprotein IIb/IIIa (Gp(IIb/IIIa)) antagonist therapy necessary to minimize thrombotic complications in patients undergoing percutaneous coronary intervention (PCI) is a subject of debate. The degree of platelet inhibition obtained 10 min after sta...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier
2013
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3861195/ https://ncbi.nlm.nih.gov/pubmed/23647894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2012.08.007 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|